Production (Stage)
STAAR Surgical Company
STAA
$18.68
-$0.09-0.48%
NASDAQ
| 03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | |
|---|---|---|---|---|---|
| Revenue | -44.94% | -35.82% | 10.31% | 7.26% | 5.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -44.94% | -35.82% | 10.31% | 7.26% | 5.21% |
| Cost of Revenue | -10.64% | 11.28% | 20.59% | -4.57% | 2.22% |
| Gross Profit | -54.12% | -47.88% | 7.62% | 10.87% | 6.03% |
| SG&A Expenses | -1.70% | 24.88% | 5.28% | 4.12% | 12.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.89% | 19.23% | 12.00% | 4.05% | 12.59% |
| Operating Income | -1,464.98% | -334.83% | -9.39% | 38.33% | -177.70% |
| Income Before Tax | -2,364.31% | -320.79% | 95.06% | 21.69% | -146.85% |
| Income Tax Expenses | -124.38% | -34.92% | 64.80% | 21.71% | -43.85% |
| Earnings from Continuing Operations | -1,523.57% | -541.31% | 107.18% | 21.69% | -223.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,523.57% | -541.31% | 107.18% | 21.69% | -223.21% |
| EBIT | -1,464.98% | -334.83% | -9.39% | 38.33% | -177.70% |
| EBITDA | -3,203.68% | -294.88% | -2.37% | 33.55% | -124.65% |
| EPS Basic | -1,508.49% | -537.26% | 104.64% | 19.97% | -221.53% |
| Normalized Basic EPS | -1,324.38% | -298.66% | 92.85% | 19.98% | -146.32% |
| EPS Diluted | -1,471.43% | -537.26% | 101.82% | 25.00% | -240.00% |
| Normalized Diluted EPS | -1,324.38% | -300.42% | 93.68% | 20.99% | -147.48% |
| Average Basic Shares Outstanding | 0.89% | 0.92% | 1.21% | 1.46% | 1.37% |
| Average Diluted Shares Outstanding | 0.89% | 0.05% | 0.73% | 0.60% | -1.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |